Terms and Conditions for Using Halenivexa

Learn more about your rights and responsibilities when accessing and using the Halenivexa website. These terms set out acceptable use, intellectual property, and legal matters to ensure a safe and transparent user experience.

These terms were updated on December 30, 2025.

Accepting Our Terms

By accessing or using our website, you agree to comply with these terms and conditions, our privacy policy, and all applicable laws. Please review these documents carefully before using our services. Continuing to use the website signifies your acceptance of any changes or updates made to our terms.

Definitions

The definitions below clarify key terms used throughout these terms and conditions for easier understanding.

  • 'Website' refers to the halenivexa.sbs platform and all associated web pages and content owned by Halenivexa.
  • 'User', 'you', or 'your' means any individual or entity accessing or using the Halenivexa website or services.
  • 'Content' covers all text, images, audio, video, graphics, code, and other information displayed on halenivexa.sbs.
  • 'Services' relates to the features and resources available on halenivexa.sbs, unless otherwise stated.

Using Our Services

Your access to halenivexa.sbs must comply with these terms, as well as applicable Australian laws. All service features are provided as is, and availability may change at our discretion.

Eligibility

Users must be at least 18 years old and capable of forming a binding contract under Australian law to access this website. By using Halenivexa, you confirm your eligibility to agree to these terms.

This website is not intended for individuals under 18 years of age.

User Responsibilities

By using Halenivexa, you acknowledge and accept the following user obligations:

  • Provide accurate, current, and complete information if submitting details through our forms.
  • Use the website in compliance with all relevant laws and do not infringe on the rights of others.
  • Safeguard account information (if any) and notify us immediately of any unauthorized access.
  • Respect the intellectual property and content ownership rights as described in this document.

Prohibited Uses

You must not use Halenivexa for any unlawful, abusive, or harmful activities.

  • Engaging in activities that violate any applicable laws or regulations.
  • Transmitting malicious software, spam, or unauthorized commercial communications.
  • Attempting to gain unauthorized access to our systems or data.
  • Infringing upon intellectual property rights of Halenivexa or third parties.
  • Engaging in conduct that is fraudulent, disruptive, or threatens platform security.

Intellectual Property Rights

All website content, trademarks, and branding are the exclusive property of Halenivexa or its licensors. You may not reproduce, reuse, or distribute any materials without prior written consent except as permitted by law. Any unauthorized use is prohibited and may be subject to legal action.

User Content Submissions

You may submit comments, ideas, or feedback; however, you agree not to submit unlawful or offensive material. We reserve the right to review and remove any submissions that violate our standards.

Rights You Grant Us:

By submitting content, you grant Halenivexa a non-exclusive, worldwide, royalty-free license to use, reproduce, or display your submission as part of the website's operation.

Privacy and Data Protection Policies

Your privacy matters to us. Please review our privacy policy to understand how your information is collected, stored, and managed in compliance with Australian regulations. View Privacy Policy

Disclaimer and Limitation of Liability

Please note some risks are inherent when accessing or using our digital services. We do not guarantee uninterrupted access to the website.

Important Notice:

Results may vary when using resources or information provided. Halenivexa is not liable for any loss, damages, or disruptions arising from your use of this website or associated content.

Limitation of Liability

Our platform is provided 'as is' without warranties of any kind. To the extent permitted by law, Halenivexa disclaims liability for losses or damages related to website usage.

Indemnification

You agree to defend, indemnify, and hold harmless Halenivexa, its affiliates, and staff from any claims or demands arising from your use of the website or violation of these terms.

Dispute Resolution and Complaints

If you have concerns regarding these terms, please contact us first. We aim to resolve disputes promptly and fairly.

Arbitration

Certain disputes may be subject to arbitration under Australian law, rather than going through court proceedings.

You may have additional rights depending on your jurisdiction.

Online Dispute Resolution Platform

The Australian Online Dispute Resolution platform offers a way to resolve disagreements without going to court. You can access their services for cross-border disputes involving online transactions.

Learn more about online dispute resolution: Learn more about online dispute resolution

Applicable Laws and Jurisdiction

These terms are governed by Australian law. Legal proceedings must be initiated in the courts located within Australia.

Termination

We reserve the right to suspend or terminate access if you breach these terms or engage in improper conduct as determined by Halenivexa.

Modifications

We may change these terms at any time. Continued use of the website implies acceptance of any updates or revisions.

Severability

If any provision of these terms is found invalid, the remaining sections remain enforceable to the extent permitted by law.

Entire Agreement

These terms, together with our privacy policy, represent the full agreement between you and Halenivexa regarding website use.

Contact for Terms and Conditions

For more information or questions about these terms and conditions, contact Halenivexa using the details below.

Email address: content@halenivexa.sbs

Phone: +61340569481

Address: 113 Exhibition St, Melbourne, VIC 3000 Australia

Effective Date of Terms: These terms take effect as of December 30, 2025.

Version: 2.1